IP Library Granted Patent US 7,905,825
Granted Patent B2
US 7,905,825 · App. 11/347,063 · Granted Mar 15, 2011

Pelvic implants and related methods

Assignee: AMS Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,905,825
App. No.
11/347,063
Granted
Mar 15, 2011
Kind
B2
Abstract

Described are surgical implants that include a central support portion adapted to be positioned to support pelvic tissue, between mesh end portions adapted to be passed through body tissue, wherein edges of the end portions exhibit extensions that are resistant to deformation.

Claims (31)

1. A surgical implant comprising an open pore elongate strip, the strip comprising

two edges comprising edge extensions, and

reinforcement comprising lines of heat treated strip adjacent to the edges and not including the edges, the reinforcement causing an increase in the force required to pull the strip through tissue,

wherein the implant is adapted to be implanted in contact with body tissue, the implant comprising:

a central support portion,

the open pore elongate strip comprising open pore mesh having opposed mesh edges and formed of strands arranged to define mesh pores, strand ends extending outwardly of the opposed mesh edges as edge extensions; and

melted strands of mesh adjacent to un-melted edge extensions.

2. A surgical implant comprising an open pore elongate strip comprising two opposing surfaces and edges having edge extensions, the edge extensions coated with a stiffening material that increases stiffness of the edge extensions, the strip comprising un-coated area on at least one surface between the coated edge extensions of the at least one surface.

3. The surgical implant of claim 2 , wherein the coating comprises a biodegradable polymer.

4. A surgical implant according to claim 2 , adapted to be implanted in contact with body tissue, the implant comprising:

the open pore elongate strip comprising resilient open pore mesh having opposed mesh side edges and formed of strands arranged to define mesh pores adapted to enable tissue ingrowth therethrough, the elongate strip exhibiting strand ends extending outwardly of the opposed mesh side edges; and

a coating of stiffening material applied to the outwardly extending strand ends to stiffen the outwardly extending strand ends to resist deformation when placed in contact with tissue,

wherein the stiffening material comprises a soluble material selected from the group consisting of mannitol, dextrose, sorbose, sucrose, sodium chloride, potassium chloride, and sodium carbonate.

5. The implant of claim 4 wherein the stiffening material comprises a soluble material selected from the group consisting of dextrose, sorbose, sodium chloride, potassium chloride, and sodium carbonate.

6. A method of preparing an implant, the method comprising:

providing an open pore elongate strip comprising edges,

heat treating material of the strip along a line adjacent to an edge to cause edge extensions to be stiffened and thereby increase the force required to pull the strip through tissue, wherein

the open pore elongate strip comprises a mesh and the edge extensions comprise severed mesh strand, and

the method comprises thermally treating mesh adjacent the edge extensions without melting the edge extensions.

7. A method of preparing an implantable sling, the method comprising:

providing an open mesh pore elongate strip comprising two opposing surfaces, edges and edge extensions,

coating edge extensions with stiffening material to increase stiffness of the extensions, while leaving uncoated area on at least one surface between the coated edge extensions of the at least one surface.

8. The implant of claim 7 , wherein the stiffening material comprises a soluble material selected from the group consisting of mannitol, dextrose, sorbose, sucrose, sodium chloride, potassium chloride, and sodium carbonate.

9. The implant of claim 7 wherein the stiffening material comprises a soluble material selected from the group consisting of dextrose, sorbose, sodium chloride, potassium chloride, and sodium carbonate.

10. A method of preparing an implant, the method comprising:

providing a sheet of open pore mesh material,

reinforcing a portion of the open pore mesh material with reinforcement selected from the group consisting of: a reinforcing weave, a reinforcing elongate strand, a strip of adhesive, and melted mesh material, to produce a reinforced portion, and

after reinforcing, cutting the material to produce an elongate mesh strip having edges with reinforced edge extensions, wherein cut edges include edge extensions of severed mesh strands adjacent to the reinforcement.

11. The method of claim 10 , wherein the reinforcement comprises a length of melted mesh material aligned with open pores of the open pore mesh material.

12. A surgical implant comprising an open pore elongate strip comprising edges having edge extensions, the edge extensions coated with a stiffening material that increases stiffness of the edge extensions, the stiffening material selected from the group consisting of mannitol, dextrose, sorbose, sucrose, sodium chloride, potassium chloride, and sodium carbonate.

13. The implant of claim 12 wherein the stiffening material comprises a soluble material selected from the group consisting of dextrose, sorbose, sodium chloride, potassium chloride, and sodium carbonate.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2016
From: AMS RESEARCH, LLC
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 037901/0941 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2016
From: AMERICAN MEDICAL SYSTEMS, LLC
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 037901/0883 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
SECURITY AGREEMENT Recorded Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2006
From: ARNAL, KEVIN R.; HAUSCHILD, SIDNEY F.; JACOBS, PETER A.; ROYCHOWDHURY, SURANJAN
To: AMS RESEARCH CORPORATION
Reel/Frame 017879/0203 →
Continuity (8)
Provisional Application 60650208 · Feb 4, 2005
Provisional Application 60650209 · Feb 4, 2005
Provisional Application 60659714 · Mar 8, 2005
Provisional Application 60659504 · Mar 8, 2005
Provisional Application 60677457 · May 4, 2005
Provisional Application 60683185 · May 20, 2005
Provisional Application 60650207 · Feb 4, 2005
Related Publication 20060195011A1 · Aug 31, 2006